Lower riskDrug recall · FDA · Published June 6, 2023
HF Acquisition Co recalls glycopyrrolate injection due to labeling mix-up
HF Acquisition Co recalls glycopyrrolate injection vials with potential labeling mix-up. This affects specific lot numbers and expiration dates. Consumers should check their product details.
“HF Acquisition Co recalls glycopyrrolate injection due to labeling mix-up.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33413-hf-acquisition-co-recalls-glycopyrrolate-injection-due-to-labeling-mix. Based on FDA recall #D-0870-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0870-2023%22&limit=1).
HF Acquisition Co LLC voluntarily recalled Glycopyrrolate Injection USP due to a labeling mix-up hazard, according to the FDA on June 6, 2023.
The recall addresses a labeling mix-up involving the specified injection product. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show HF Acquisition Co LLC has 5 other recalls on record since June 4, 2020. Other recent recalls of similar products include American Health Packaging Buprenorphine Tablets Recall (Aug. 19, 2026), Precision Dose Glycopyrrolate Oral Solution Recall (July 14, 2026), and Wells Pharma fentanyl injectable solution recall (April 1, 2026).
How to tell if you have this one
Check for the lot number 2205095.1 and expiration date 7/31/2024 on the vial. The product is a glycopyrrolate injection vial with NDC 51662-1487-3.
Brand
HF Acquisition Co
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number 2205095.1 and expiration date 7/31/2024 on the vial.
Where it went and when
Where it was distributed
Distributed in 3 states.
Listed by the agency
Not listed
FDA distribution: “Distributed in TX, AZ and CA only” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Arizona, California, Texas.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0870-2023 (June 6, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0870-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.